The new FDA guidance document for ISO 10993-1 focuses on a risk based approach to biocompatibility. The first step is to develop a BEP. This webinar will go over the thought process and information needed to develop a useful testing plan.
Duration:
60-minutes
Dates and locations:
Available On Demand
Hosted by: